Neuren Pharmaceuticals LimitedASX: NEU

FDA approval for Angelman IND and Phase 2 trial

Feb 25, 2022 at 3:52 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment